What Pfizer’s vaccine news means for employers
Nationwide availability of a COVID-19 vaccine is still months away, experts warn. Here are the messages you should be sending to employees right now.
Editor’s Note: We’re sharing an article from our new sister brand Workplace Wellness Insider. Typically this would be a premium, subscriber-only article, but we’re freeing it up so you can get a taste of the content we’re offering on this site.
Good news came from Pfizer Monday about the outlook for its experimental COVID-19 vaccine, which it says is 90% effective. That’s well above the threshold of 50% effective that the government set for a viable vaccine earlier this year and compares well with vaccines like the flu shot.
“This result is towards the high end of expectations,” said an emailed comment from Shane Crotty, professor at the Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology. “Greater than 90% efficacy at preventing disease, with 94 COVID-19 cases to evaluate, is an excellent outcome! It would be good to see more of the data, but those are very convincing numbers.”
It’s a good sign, according to medical experts, but the process isn’t yet over.
Become a Ragan Insider member to read this article and all other archived content.
Sign up today
Already a member? Log in here.
Learn more about Ragan Insider.
